Selective coverage radiotherapy for thyroid carcinoma, anaplastic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 12 Aug 2026: Trial started, NCT07777536
  2. 20 Aug 2026: Trial registered, NCT07777536

The trials

NCT07777536: Selective Coverage Versus Comprehensive Coverage Radiotherapy in Poorly Differentiated and Anaplastic Thyroid Cancer

State
Under way
Phase
Phase 2
People
72 planned
Started
12 Aug 2026
Primary completion
31 Jul 2031
Arms
Selective coverage radiotherapy
Results
None posted
  1. 12 Aug 2026: Trial started
  2. 20 Aug 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.